DOWDEN NATHAN J (Chief Operating Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2026ACC: 0001873392-26-000006
Officer· Chief Operating Officer
Since Oct 2021
-2.53K
Net shares
Net seller
$18.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.53K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.53K
Price / share
$7.14
Trade value
$18.06K
% of position
1.3%
9/2/2026
198.59K→196.06K
Total
Net shares
−2.53K
Net value
-$18.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −2.53K | $7.14 | $18.06K | 1.3% | 198.59K | 196.06K |
| Total | −2.53K | -$18.06K | ||||||
Derivative Transactions0
No derivative transactions reported